81 related articles for article (PubMed ID: 380077)
1. In vivo activity of an H-2 alloantiserum purified by affinity chromatography on transplantation antigens.
de Waal RM; Lems SP; Koene RA
Transplantation; 1979 Jun; 27(6):376-9. PubMed ID: 380077
[TBL] [Abstract][Full Text] [Related]
2. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
de Waal RM; Capel PJ; Koene RA
J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
[TBL] [Abstract][Full Text] [Related]
3. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
Duc HT; Kinsky RG; Voisin GA
Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
[TBL] [Abstract][Full Text] [Related]
4. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
Staines NA; Guy K; Davies DA
Eur J Immunol; 1975 Nov; 5(11):782-9. PubMed ID: 802473
[TBL] [Abstract][Full Text] [Related]
5. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
Perry LL; Williams IR
J Immunol; 1985 May; 134(5):2935-41. PubMed ID: 2580008
[TBL] [Abstract][Full Text] [Related]
6. Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF.
Noro N; Adachi M; Yasuda K; Masuda T; Yodoi J
J Immunol; 1986 Apr; 136(8):2910-6. PubMed ID: 3514749
[TBL] [Abstract][Full Text] [Related]
7. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
Jansen JL; Gerard AP; Kamp J; Tamboer WP; Wijdeveld PG
J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
[TBL] [Abstract][Full Text] [Related]
8. Procedure for the isolation of mouse anti H-2 antibodies from complex alloantisera.
De Waal RM; Koene RA
J Immunol Methods; 1977; 14(3-4):225-9. PubMed ID: 402423
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification.
Stallcup KC; Springer TA; Mescher MF
J Immunol; 1981 Sep; 127(3):923-30. PubMed ID: 6167633
[TBL] [Abstract][Full Text] [Related]
10. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
11. The histocompatibility-2 system in wild mice. XII. An immunochemical analysis of the anti-Ia antibodies in antisera produced against 13 B10.W lines.
Wakeland EK; Klein J
J Immunol; 1981 May; 126(5):1731-6. PubMed ID: 6938607
[TBL] [Abstract][Full Text] [Related]
12. Evidence for homologues of the murine I-A and I-E loci in the rat MHC.
Shinohara N; Sachs DH
J Immunol; 1981 Mar; 126(3):934-7. PubMed ID: 6970226
[TBL] [Abstract][Full Text] [Related]
13. Identification of murine placental glycoproteins in relation to in vivo and in vitro immunomodulatory properties against H-2 antigens.
Gupta GS; Kinsky RG
Nephrologie; 1988; 9(4):167-75. PubMed ID: 2975359
[TBL] [Abstract][Full Text] [Related]
14. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
[TBL] [Abstract][Full Text] [Related]
15. Differences in expression of MHC products between several H-2-restricted CTL clones.
Hauptfeld V; Braciale TJ; Shreffler DC
J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
[TBL] [Abstract][Full Text] [Related]
16. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
Isakov N; Bach FH
J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
[TBL] [Abstract][Full Text] [Related]
17. Alloantiserum-induced inhibition of immune response gene product function. II. Genetic analysis of target antigens.
Shevach EM; Green I; Paul WE
J Exp Med; 1974 Mar; 139(3):679-95. PubMed ID: 4591175
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
19. Detection of at least two distinct mouse I-E antigen molecules by the use of a monoclonal antibody.
Ozato K; Sachs DH
J Immunol; 1982 Feb; 128(2):807-10. PubMed ID: 6948041
[TBL] [Abstract][Full Text] [Related]
20. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
